Jules Bordet Institute
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1939-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.bordet.be
Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
Not Applicable
Not yet recruiting
- Conditions
- OligoProgressive Metastatic Disease
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 48
- Registration Number
- NCT06925984
- Locations
- 🇧🇪
CHU UCL Namur - Site Saint Elisabeth, Namur, Belgium
🇧🇪Jules Bordet Institute, Brussels, Belgium
🇧🇪UZ Gent, Ghent, Belgium
The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)
Not Applicable
Recruiting
- Conditions
- Multiparametric MRILesion PI-RADS 3
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-31
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 68
- Registration Number
- NCT06867588
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
HER2 Molecular Imaging with 89Zr-trastuzumab PET/CT As a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients with Advanced HER2-positive Breast Cancer
Phase 2
Not yet recruiting
- Conditions
- HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
- Interventions
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 87
- Registration Number
- NCT06595563
Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Radiation: SOC RTRadiation: stereotactic body radiotherapy
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 284
- Registration Number
- NCT06523634
- Locations
- 🇧🇪
AZorg, Aalst, Belgium
🇧🇪Ziekenhuis Aan de Stroom (ZAS), Antwerpen, Belgium
🇧🇪Jules Bordet Institute, H.U.B, Brussels, Belgium
Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers
Not Applicable
Not yet recruiting
- Conditions
- Pelvic CancerRectum Cancer
- Interventions
- Device: Magnetic Resonance Imaging (MRI)
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06458725
A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients with Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors
Phase 1
Withdrawn
- Conditions
- Multiple Myeloma in RelapseMultiple Myeloma, RefractoryMultiple Myeloma Progression
- Interventions
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06411301
- Locations
- 🇧🇪
Jules Bordet Institute, Brussels, Belgium
Effects of Oxygen After Abdominal Oncological Surgery
Not Applicable
Completed
- Conditions
- Abdominal Cancer
- Interventions
- Procedure: Oxygen
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 49
- Registration Number
- NCT06321874
- Locations
- 🇧🇪
Khalife Maher, Brussels, Belgium
Evaluation of the RESTART Survival Programme
Not yet recruiting
- Conditions
- Invasive Breast Cancer
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 200
- Registration Number
- NCT06283511
Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases
Not Applicable
Completed
- Conditions
- Carcinomatosis, Peritoneal
- Interventions
- Procedure: epigastric lymph node biopsy
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 20
- Registration Number
- NCT06237582
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 250
- Registration Number
- NCT06227338
- Locations
- 🇧🇪
Jules Bordet Institute, Brussels, Belgium
© Copyright 2025. All Rights Reserved by MedPath